Letter to the editor: Efficacy of probiotic treatment as postexposure prophylaxis for COVID-19: A double-blind, PlaceboControlled randomized trial

Clin Nutr. 2024 Jun;43(6):1501-1502. doi: 10.1016/j.clnu.2024.05.006. Epub 2024 May 6.

Authors

Yuan Ji¹, Jinhan Chen¹, Yuying Chi¹, Yuou Ying¹, Mingxian Chen²

Affiliations

¹ The Second Affiliated College of Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang Province, China.
² Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Street Gucui No.234, Region Xihu, Hangzhou 310012, Zhejiang Province, China. Electronic address: chenmingxian2005@126.com.

PMID: 38723305
DOI: 10.1016/j.clnu.2024.05.006

No abstract available

Keywords: Autoimmunity; COVID-19; Diet and exercise; Hierarchical treatment; Probiotic.

Publication types

Letter
Randomized Controlled Trial

MeSH terms

COVID-19* / prevention & control
Double-Blind Method
Humans
Post-Exposure Prophylaxis* / methods
Probiotics* / administration & dosage
Probiotics* / therapeutic use
SARS-CoV-2
Treatment Outcome